Blog > US Stocks and Markets > Blog article: Are Pfizer (PFE) and Merck (MRK) good cheap buys?
 | Email This Article Email This Article  | 

Are Pfizer (PFE) and Merck (MRK) good cheap buys?

Posted June 13, 2008

“Is it time to start looking at pharma as a value play and buy some shares?” — Rick Pendergraft, Early to Rise

by Rick Pendergraft

Baltimore – (TFN): As a result of the legal issues big-name companies like Pfizer (PFE) and Merck (MRK) have been dealing with, the pharmaceutical industry is among the worst performing industries so far in 2008.

Several ETFs provide exposure to this sector, but the two that see most of the trading volume are the Pharmaceutical HOLDRs Trust (PPH) and the Select Healthcare Spyder (XLV). The performance of these two ETFs has been abysmal over the past year, with the PPH down 17.24 percent and the XLV down 11.13 percent. During this same time period, the S&P 500 was down only 6.54 percent. So you can see how the pharmaceutical sector has been lagging behind the rest of the market.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

The Real Estate Deal of a Lifetime: Lots start at just $36,000 in this premiere Pacific beachside community.

The developers of Rancho Santana, are rapidly becoming masters at putting together alluring real estate deals. And this one’s no exception. You’ll want to secure a $36,000 lot in this premiere Pacific beachside community.

Learn more…

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Is it time to start looking at pharma as a value play and buy some shares? Read on to learn more.

****Make sure you sign up for our free TFN News Feed for breaking news, special reports and new financial videos. You can pick your favorite reader . Or if you prefer, you can have or free daily email delivered to your inbox .


Related Articles


Posted by Rick Pendergraft · Filed Under US Stocks and Markets 

Comments

close Reblog this comment
Powered by Disqus · Learn more
blog comments powered by Disqus